cells Review Progenitor/Stem Cells in Vascular Remodeling during Pulmonary Arterial Hypertension France Dierick 1 , Julien Solinc 2, Juliette Bignard 2, Florent Soubrier 2 and Sophie Nadaud 2,* 1 Lady Davis Institute for Medical Research, McGill University, Montréal, QC H3T 1E2, Canada;
[email protected] 2 UMR_S 1166, Faculté de Médecine Pitié-Salpêtrière, INSERM, Sorbonne Université, 75013 Paris, France;
[email protected] (J.S.);
[email protected] (J.B.); fl
[email protected] (F.S.) * Correspondence:
[email protected] Abstract: Pulmonary arterial hypertension (PAH) is characterized by an important occlusive vascular remodeling with the production of new endothelial cells, smooth muscle cells, myofibroblasts, and fibroblasts. Identifying the cellular processes leading to vascular proliferation and dysfunction is a major goal in order to decipher the mechanisms leading to PAH development. In addition to in situ proliferation of vascular cells, studies from the past 20 years have unveiled the role of circulating and resident vascular in pulmonary vascular remodeling. This review aims at summarizing the current knowledge on the different progenitor and stem cells that have been shown to participate in pulmonary vascular lesions and on the pathways regulating their recruitment during PAH. Finally, this review also addresses the therapeutic potential of circulating endothelial progenitor cells and mesenchymal stem cells. Keywords: pulmonary arterial hypertension; vascular remodeling;